or breastfeeding
Non-prescription and compounded peptides such as BPC-157, CJC-1295/Ipamorelin, AOD-9604, and MOTS-c are not FDA-approved for weight loss and lack the same regulatory oversight and clinical safety data as the GLP-1 drugs in the table above, which is why they should only be used under the guidance of a licensed medical provider who can order lab work, personalize dosing, and monitor for side effects throughout treatment
Couffinhal, T., Duplaa, C., Moreau, C., Lamaziere, J
But rapid weight loss without adequate protein intake and resistance training absolutely can reduce lean mass
Its essential to separate motility effects from the measurement accuracy to preserve the significant diagnostic value of breath testing for SIBO, Intestinal Methanogen Overgrowth (IMO), and carbohydrate malabsorption evaluations